METIRRA Trademark

Trademark Overview


On Wednesday, July 9, 2025, a trademark application was filed for METIRRA with the United States Patent and Trademark Office. The USPTO has given the METIRRA trademark a serial number of 79432839. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, April 14, 2026. This trademark is owned by Envision Sciences Pty Ltd. The METIRRA trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical use, namely, biological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; dia...

Disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical services, namely, consulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis, and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer prevention, screening, diagnosis, and treatment; medical information; consulting services in the field of medical care
metirra

General Information


Serial Number79432839
Word MarkMETIRRA
Filing DateWednesday, July 9, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, April 14, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2026

Trademark Statements


Goods and ServicesPharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical use, namely, biological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeutics, namely, therapeutic pharmaceutical for the treatment of cancer; pharmaceutical biosimilars for human use for the treatment of cancer; medical preparations, namely, immunotherapeutic agents for the treatment and prevention of cancers and tumors; diagnostic biomarkers and medical antibodies for use in medical imaging
Goods and ServicesDisease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical services, namely, consulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer prevention, screening, diagnosis, and treatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer prevention, screening, diagnosis, and treatment; medical information; consulting services in the field of medical care

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 26, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMetirra Pty Ltd
Party Type11 - New Owner Before Publication
Legal Entity Type99 - Other
AddressAU

Party NameEnvision Sciences Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type98 - Unknown
AddressAU

Trademark Events


Event DateEvent Description
Thursday, September 18, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, September 26, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 22, 2026CHANGE OF NAME/ADDRESS REC'D FROM IB
Wednesday, January 28, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 28, 2026APPLICATION FILING RECEIPT MAILED
Thursday, January 29, 2026ASSIGNED TO EXAMINER
Thursday, January 29, 2026NON-FINAL ACTION WRITTEN
Friday, January 30, 2026NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, February 26, 2026REFUSAL PROCESSED BY MPU
Thursday, February 26, 2026NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 12, 2026REFUSAL PROCESSED BY IB
Friday, March 13, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 13, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 13, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 13, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 1, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 1, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 1, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 6, 2026APPROVED FOR PUB - PRINCIPAL REGISTER